Branden Moriarity, PhD
As a translational genome engineer, Branden Moriarity develops and translates novel cellular immunotherapies to treat cancer and genetic diseases in collaboration with colleagues at the University of Minnesota, as well as national and international partners. In his short career, his laboratory has initiated more than 5 clinical trials and has numerous additional cutting-edge cellular therapies in preclinical development that will be translated into novel clinical trials over the next few years. Dr. Moriarity is an Associate Professor in the Department of Pediatrics, a faculty member in the Division of Pediatric Hematology/Oncology, Co-Director of the Center for Gnome Editing as well as a faculty member in four additional UMN Masters and Graduate Programs.